Argos Therapeutics

Will Argos Therapeutics survive their lack of cash and long runway to BLA filing, buildout of new facility, "dream" of automation?

 

Never ... at least with their current management team. The lack of experience is really hurting this once promising company.

 

Here comes the implosion just in advance of 3Q earnings call. Will ARGS dip below $4 per share? If so, not a great sign as they clearly need to raise capital soon. The ship is sinking ....

 

Wow - 23MM left and burning 6MM monthly. Not sure how that gets them to 2Q 2016 per their earnings call yesterday, but they must be ready to lay off folks and put their new facility and dreams of "automation" on hold. Not sure how they will survive this continued implosion from their HIV data debacle in January 2016.

 

Stock at all time low in the 2.30 - 2.40 range. Implosion in process. No cash on hand at some point 1Q 2016 ... wow!!

 

Don't count Argos out yet. With leadership buying stock and a meeting on the 16th with investors - they may have an ace up their sleeve.

 

Wishful thinking from an insider - will be interesting to see if anything happens this Wed 12/16! For long term success, they will need to make significant changes from the top through mid-level management. They simply do not have a formula for success ... yet.

 

What is going on at Argos as they run out of money in the next few weeks? Great question - as the company's share price has 3-4 fold in the past 8 weeks and yet they are on the verge of shutting down without a significant capital raise!! This stock price run up amidst only negative company news (e.g., lack of any positive news in months) smells awfully suspicious of the typical Wall Street behind the scenes shenanigans. Someone is inflating the stock price hoping to suck unaware investors into the equation. BUYERS BEWARE!!!

 

You are a dumb ass. They got 60 million today. Go troll somewhere else.

 

Argo- Phuck yourself

 

No - you are the DUMB ASS and probably an insider. Reality is they only got $20MM at present and now have hurdles to overcome and a long, long runway. If their 50% readout from their phase 3 study isn't happening until June 2016 ... that means it's taken about a year from the 25% interim. If the phase 3 study is positive, this means that their final readout won't happen until 2018. Okay, so let's use basic math, since you are a DUMB ASS. 60MM divided by 4MM per month for operating costs they are sinking into their "dream" of automating and the new manufacturing facility that might turn into a storage warehouse ... that's 15 months. They were on fumes this month ... so 15 months into the future is only May/June 2017 ... they will be at best at 75% of data readout ... probably not if the data are positive.

This was a PRIVATE placement from insiders and 1 investor from their IPO. What does that say? It says they will have to continue to compile debt, warrants, etc ... You are the DUMB ASS for investing if you have ... STOCK will plummet once people figure out how desperate they were and how far this money (if it all comes in) will NOT take the company and their effort to get to a final readout from a pivotal RCC study.

JOKE is on you ... DUMB ASS!!!

 

So, for the DUMB A** who replied above and indicating the company raised $60MM, you can go BLANK yourself. Why? Because you're clearly an INSIDER and/or are simply STUPID. Why? The milestones and warrants and conditions of the PRIVATE PLACEMENT (no public investors excluding their largest institutional investor from the IPO came into this private, behind the scenes round) indicate the company only brought in $20MM which gives them a 5 month runway. Assuming their data readout is "neutral", it will NOT be "positive" this June 2016 (if you don't understand basic math DA I know you don't understand stats and trial outcomes and readouts).

Regardless of this DAs opinion - it's clear the company CAN'T raise money in the PUBLIC markets as there is no confidence in the leadership team on the outside of the core insiders. Why? They've burned through 100s of millions and clearly been distracted by a DREAM of automation and NEW FACILITY that burned through their IPO proceeds more quickly than anticipated.

MARK this thread and this PREDICTION - they will not have final data for their phase 3 study until mid-2018 at the earliest based upon their prediction of a positive outcome (data readout takes longer ... 25% last June ... if 50% this June ... they need a much longer runway for their curves to separate and a significant benefit to be evident). If final data readout happens 2Q18 ... they run out of the up to $60MM from this PRIVATE not PUBLIC round by May / June 2017.

What the HECK are they going to do THEN? Let us KNOW DUMB A**. You seem to have ALL The answers. If you're an INSIDER - STOP POSTING BS. If you're an INVESTOR - STOP the BS Postings on HERE.

EVERYONE ELSE - BUYER BEWARE. The fundamentals are WEAK, RUNWAY to DATA is LONG and if you want a near term ROI with a HIGHER PROBABILITY of SUCCESS ... LOOK ELSEWHERE in the BIOTECH REALM!!! HA!

 

You are a miserable soul. I pity you.

Please seek help before you harm yourself or others.

 

Well spoken for an insider / employee! Perhaps you can shed some light on whether or not data read out will "really" happen in the next 12 months. Seems highly unlikely, since you are at mid-point or so June 2016. If the other 50% of events read out by June 2017 ... that can only mean ONE outcome. You'll be searching for new employment by then.

For insiders - start your own post. This post is here to inform outsiders and investors and ensure everyone understands the Argos reality.

 

Earnings call next Tuesday 3/29 - should be interesting to hear how they spin their recent financing, cash runway and timing to data. All investors should flood the lines and ask the tough questions ... if they are just getting to 50% of data for their kidney study ... how are they getting to final data in 12 months? Based upon what the other posts have been stating (accurate) .. it's clear that readout in 12 months would be negative. Hmmm - look how long it took Bristol's product opdivo to generate a survival benefit that was significant. These studies seem to take years when small biotech companies want to commit to months ...

 

Don't be fooled by stock fluctuation and run up ... it's all happening prior to the "earnings" call to protect against further stock price erosion. Predicting company will be on fumes by early 2017 and stock will sink back to $2 range between now and then. Buyers BEWARE! Employees be LOOKING!

 

insiders and inside bankers are running up stick in advance of earnings. Recent news is non event ... Phase 3 readout is positive is at least 2 years away ... "Up to 60MM" if primarily insider funds gets this company to 2Q17 unless they layoff 50% of employees and conserve.

Buyers continue to beware. False perceptions create empty accounts!!!

 

Earnings call was a snooze and SOS just a different quarter and year. Overpromising data readout timeline of 1H 2017. They reported about 25% data last June, apparently are close to 50% of data for this June and thus, unless the trial is negative ... it should not read out for another 18-24 months.

Burning lots of cash in 2015 and no facility agreement to prepare for commercial production. The company needs a real plan of action in the coming weeks to address, but there biggest issue continues to be getting more than the "up to 60MM", which only lasts 12-15 months based upon their burn rate. They will need another 30-60MM to get to a positive data readout. Is that coming from the private investors again? They better hope so, as the public markets were crushing this company through early 2016 when they were clearly running out of cash.

Hold onto your seats everyone that's invested and considering investing - this is going to be a wild ride with more downs than ups ...

Employees better run for the hills. Won't be pretty when they start eliminating positions to conserve cash when they don't reach their data readout in early 2017.

 

ATTENTION dumb ass schizophrenic troll who posts and then answers himself. Yes you - the only one who is in this board.

Check today's stock price and take another bite of crow. Looks like your predictions are baseless and you are a disgruntled ex-employee. Don't play with 'His Money'.

Maybe you should concentrate on your job at McDonalds and work in getting out of your mom's basement. Apparently you don't know jack! You are a LOSER!

 

Haha - spoken like a twisted insider. No prior employees here. Just pissed off investors who are getting FOOLED by your company's LIES and INUENDOS.

FOLKS - CURRENT and FUTURE INVESTORS - Don't be fooled by this INSIDER RUN UP in stock price. The company is WORTHLESS UNTIL they prove they have POSITIVE data from their late stage study. PER VERY REPUTABLE SOURCES, the DATA will NOT BE POSITIVE (if they are) UNTIL 2018!!!!!!!

Company has track record of POOR LEADERSHIP and MANAGEMENT, hence why they could only raise UP TO 60MM (note the fine print in their press release) FROM INSIDERS and couldn't come back to the STREET to get any more cash.

They WILL fail with current MANAGEMENT and STRATEGY even if DATA are positive. SOMEBODY ELSE is going to have to ACQUIRE this fledgling, debt-ridden company prior to having success with their platform.

The INSIDER posting the above message should know to stay away from CAFE PHARMA ... it will come back to BITE YOU and the LOSER you are. Have a NON F-NICE DAY dude!